Brock University
Saint Catherines, Ontario, Canada
NCT Number: NCT03808363
Testing the efficacy of high intensity interval training (HIIT), as compared to current research supporting moderate intensity continuous training (MICT), as a means to improve cardiometabolic health after spinal cord injury.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Saint Catherines, Ontario, Canada
This study aims to challenge the effectiveness of the current aerobic exercise recommendations for individuals with spinal cord injuries (SCI). Currently, moderate intensity continuous training (MICT) is suggested however this study intends to explore the effectiveness of high intensity interval training (HIIT). To do so, approximately 8 individuals with SCI will be undergo a 6 week HIIT intervention consisting of 3 sessions per week. With a focus on cardiometabolic health markers (listed in outcome measure section), we aim to provide support for HIIT as a viable method of mitigating cardiovascular risk in a SCI population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participants assigned to this group will perform a very mild 5-minute warm-up (0 resistance, and 60 rpm), followed by 5 one-minute bouts of high intensity exercise, with 90 seconds between each bout. These bouts will be followed by a 3-minute cool down (0 resistance, and 60 rpm). The high-intensity exercise will be performed at an intensity of 17 on the Borg rating of perceived exertion (RPE) scale (very hard), and the 90 second active rest intervals will be performed at an intensity of 7-9 (very, very light - very light). The exercise will be performed on the NuStep machine 3 times a week for 6 weeks.
Other names: HIIT
Time frame: 6 weeks
Central adiposity will be measured by tape measure to monitor possible weight loss
Time frame: 6 weeks
Total and HDL cholesterol will be measured in serum
Time frame: 6 weeks
Triglycerides will be measured in serum
Time frame: 6 weeks
Glycated hemoglobin will be measured in whole blood as an indicator of diabetic risk
Time frame: 6 weeks
TNF-a will be used as an inflammatory representative and will be measured in serum
Time frame: 6 weeks
IL-10 will will be used as an anti-inflammatory representative and will be measured in serum
Time frame: 6 weeks
Arterial stiffness, a common measure for cardiac risk will be measured
Time frame: 6 weeks
Measured through a digital cuff, the focus will be on both systolic and diastolic
Time frame: 6 weeks
VO2 peak will be measured by a Moxus metabolic cart to determine changes in fitness
Time frame: 6 weeks
CRP will will be used as an inflammatory representative and will be measured in serum
Time frame: 6 weeks
Leptin will will be used as a body fat representative and will be measured in serum
Time frame: 6 weeks
Adiponectin will will be used as a surrogate for insulin resistance and will be measured in serum
Time frame: 6 weeks
All participants will complete the physical activity enjoyment scale (PACES) to indicate enjoyment of HIIT. With a total of 18 questions, options 1 through 7 going from a positive to a negative overall experience with the HIIT protocol will be documented.
Brock University
Other
High-intensity Interval Training Versus Moderate Intensity Continuous Training as a Means to Improve Cardiometabolic Health After Spinal Cord Injury
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04748835
Behavior, Behavior, Animal
Dallas, Texas, United States
View Trial DetailsNCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT04922970
Cardiovascular Diseases, Glucose Metabolism Disorders
Copenhagen, Denmark
View Trial Details